Annual Book Value
$859.34 M
+$474.39 M+123.23%
31 December 2023
Summary:
Sarepta Therapeutics annual book value is currently $859.34 million, with the most recent change of +$474.39 million (+123.23%) on 31 December 2023. During the last 3 years, it has fallen by -$68.67 million (-7.40%). SRPT annual book value is now -16.75% below its all-time high of $1.03 billion, reached on 31 December 2018.SRPT Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Book Value
$1.22 B
+$144.00 M+13.37%
30 September 2024
Summary:
Sarepta Therapeutics quarterly book value is currently $1.22 billion, with the most recent change of +$144.00 million (+13.37%) on 30 September 2024. Over the past year, it has increased by +$361.73 million (+42.09%). SRPT quarterly book value is now -9.45% below its all-time high of $1.35 billion, reached on 31 March 2019.SRPT Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRPT Book Value Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | +42.1% |
3 y3 years | -7.4% | +31.6% |
5 y5 years | +5.0% | +49.2% |
SRPT Book Value High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -7.4% | +123.2% | at high | +217.2% |
5 y | 5 years | -7.4% | +123.2% | at high | +217.2% |
alltime | all time | -16.8% | >+9999.0% | -9.4% | >+9999.0% |
Sarepta Therapeutics Book Value History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $1.22 B(+13.4%) |
June 2024 | - | $1.08 B(+12.1%) |
Mar 2024 | - | $961.19 M(+11.9%) |
Dec 2023 | $859.34 M(+123.2%) | $859.34 M(+12.4%) |
Sept 2023 | - | $764.36 M(+3.1%) |
June 2023 | - | $741.41 M(+4.0%) |
Mar 2023 | - | $712.75 M(+85.2%) |
Dec 2022 | $384.95 M(-58.5%) | $384.95 M(-10.7%) |
Sept 2022 | - | $430.84 M(-40.7%) |
June 2022 | - | $726.46 M(-15.2%) |
Mar 2022 | - | $856.89 M(-7.7%) |
Dec 2021 | $928.01 M(+21.8%) | $928.01 M(+97.6%) |
Sept 2021 | - | $469.53 M(-3.2%) |
June 2021 | - | $485.11 M(-9.4%) |
Mar 2021 | - | $535.45 M(-29.7%) |
Dec 2020 | $761.76 M(-6.9%) | $761.76 M(-14.6%) |
Sept 2020 | - | $892.05 M(-14.5%) |
June 2020 | - | $1.04 B(-8.9%) |
Mar 2020 | - | $1.14 B(+39.9%) |
Dec 2019 | $818.19 M(-20.7%) | $818.19 M(-17.8%) |
Sept 2019 | - | $995.20 M(-9.5%) |
June 2019 | - | $1.10 B(-18.5%) |
Mar 2019 | - | $1.35 B(+30.6%) |
Dec 2018 | $1.03 B(+30.8%) | $1.03 B(+61.3%) |
Sept 2018 | - | $639.85 M(-8.5%) |
June 2018 | - | $699.05 M(-10.0%) |
Mar 2018 | - | $776.76 M(-1.6%) |
Dec 2017 | $789.22 M(+134.4%) | $789.22 M(+13.2%) |
Sept 2017 | - | $697.16 M(+84.5%) |
June 2017 | - | $377.77 M(-12.0%) |
Mar 2017 | - | $429.14 M(+27.5%) |
Dec 2016 | $336.69 M(+76.9%) | $336.69 M(-17.6%) |
Sept 2016 | - | $408.62 M(+236.4%) |
June 2016 | - | $121.46 M(-12.6%) |
Mar 2016 | - | $138.96 M(-27.0%) |
Dec 2015 | $190.35 M(-23.1%) | $190.35 M(+54.5%) |
Sept 2015 | - | $123.24 M(-25.5%) |
June 2015 | - | $165.38 M(-17.6%) |
Mar 2015 | - | $200.76 M(-18.9%) |
Dec 2014 | $247.65 M(+0.2%) | $247.65 M(-13.5%) |
Sept 2014 | - | $286.20 M(-4.6%) |
June 2014 | - | $299.92 M(+31.0%) |
Mar 2014 | - | $228.96 M(-7.4%) |
Dec 2013 | $247.19 M(+99.9%) | $247.19 M(+0.1%) |
Sept 2013 | - | $246.98 M(+178.1%) |
June 2013 | - | $88.82 M(+1.8%) |
Mar 2013 | - | $87.28 M(-29.4%) |
Dec 2012 | $123.68 M(+298.7%) | $123.68 M(-2808.7%) |
Sept 2012 | - | -$4.57 M(-120.3%) |
June 2012 | - | $22.50 M(+60.5%) |
Mar 2012 | - | $14.02 M(-54.8%) |
Dec 2011 | $31.02 M(-1201.1%) | $31.02 M(-2.3%) |
Sept 2011 | - | $31.75 M(-9.7%) |
June 2011 | - | $35.15 M(+3720.5%) |
Mar 2011 | - | $920.00 K(-132.7%) |
Dec 2010 | -$2.82 M | -$2.82 M(-167.7%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2010 | - | $4.16 M(-50.7%) |
June 2010 | - | $8.44 M(-64.0%) |
Mar 2010 | - | $23.47 M(-0.7%) |
Dec 2009 | $23.63 M(+50.2%) | $23.63 M(+21.2%) |
Sept 2009 | - | $19.50 M(+414.9%) |
June 2009 | - | $3.79 M(-83.5%) |
Mar 2009 | - | $22.89 M(+45.5%) |
Dec 2008 | $15.73 M(-40.4%) | $15.73 M(-3.7%) |
Sept 2008 | - | $16.34 M(-23.1%) |
June 2008 | - | $21.24 M(+2.2%) |
Mar 2008 | - | $20.79 M(-21.2%) |
Dec 2007 | $26.38 M(-30.0%) | $26.38 M(+73.3%) |
Sept 2007 | - | $15.23 M(-37.1%) |
June 2007 | - | $24.21 M(-21.8%) |
Mar 2007 | - | $30.96 M(-17.9%) |
Dec 2006 | $37.71 M(-29.7%) | $37.71 M(-15.0%) |
Sept 2006 | - | $44.36 M(-11.5%) |
June 2006 | - | $50.12 M(-10.4%) |
Mar 2006 | - | $55.91 M(+4.2%) |
Dec 2005 | $53.66 M(+104.3%) | $53.66 M(+45.1%) |
Sept 2005 | - | $36.99 M(-4.2%) |
June 2005 | - | $38.62 M(-11.1%) |
Mar 2005 | - | $43.42 M(+65.3%) |
Dec 2004 | $26.27 M(-39.5%) | $26.27 M(-15.3%) |
Sept 2004 | - | $31.02 M(-13.8%) |
June 2004 | - | $35.98 M(-16.4%) |
Mar 2004 | - | $43.05 M(-0.8%) |
Dec 2003 | $43.39 M(+84.8%) | $43.39 M(+24.7%) |
Sept 2003 | - | $34.81 M(-9.2%) |
June 2003 | - | $38.33 M(+94.4%) |
Mar 2003 | - | $19.71 M(-16.1%) |
Dec 2002 | $23.48 M(-23.1%) | $23.48 M(-9.1%) |
Sept 2002 | - | $25.83 M(-23.1%) |
June 2002 | - | $33.58 M(-16.9%) |
Mar 2002 | - | $40.42 M(+32.4%) |
Dec 2001 | $30.53 M(-8.5%) | $30.53 M(-3.2%) |
Sept 2001 | - | $31.56 M(-16.4%) |
June 2001 | - | $37.76 M(+30.9%) |
Mar 2001 | - | $28.84 M(-13.6%) |
Dec 2000 | $33.37 M(+180.4%) | $33.37 M(-13.8%) |
Sept 2000 | - | $38.70 M(+241.8%) |
June 2000 | - | $11.32 M(-24.6%) |
Mar 2000 | - | $15.02 M(+26.3%) |
Dec 1999 | $11.90 M(+32.2%) | $11.90 M(+283.9%) |
Sept 1999 | - | $3.10 M(-41.5%) |
June 1999 | - | $5.30 M(-27.4%) |
Mar 1999 | - | $7.30 M(-18.9%) |
Dec 1998 | $9.00 M(-50.8%) | $9.00 M(-21.1%) |
Sept 1998 | - | $11.40 M(-26.0%) |
June 1998 | - | $15.40 M(-9.4%) |
Mar 1998 | - | $17.00 M(-7.1%) |
Dec 1997 | $18.30 M(+369.2%) | $18.30 M(-1.6%) |
Sept 1997 | - | $18.60 M(+5.7%) |
June 1997 | - | $17.60 M(+8700.0%) |
Mar 1997 | - | $200.00 K |
Dec 1996 | $3.90 M | - |
FAQ
- What is Sarepta Therapeutics annual book value?
- What is the all time high annual book value for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly book value?
- What is the all time high quarterly book value for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly book value year-on-year change?
What is Sarepta Therapeutics annual book value?
The current annual book value of SRPT is $859.34 M
What is the all time high annual book value for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual book value is $1.03 B
What is Sarepta Therapeutics quarterly book value?
The current quarterly book value of SRPT is $1.22 B
What is the all time high quarterly book value for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly book value is $1.35 B
What is Sarepta Therapeutics quarterly book value year-on-year change?
Over the past year, SRPT quarterly book value has changed by +$361.73 M (+42.09%)